Valuation: IRIDEX Corporation

Market Cap 15.49M 13.42M 12.57M 11.47M 21.56M 1.48B 21.89M 148M 57.8M 740M 58.15M 56.89M 2.47B P/E 2026 *
-17.8x
P/E 2027 * 44.5x
Enterprise Value 15.49M 13.42M 12.57M 11.47M 21.56M 1.48B 21.89M 148M 57.8M 740M 58.15M 56.89M 2.47B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.27x
Free-Float
62.93%
Yield 2026 *
-
Yield 2027 * -
1 day-2.56%
1 week+4.50%
Current month+7.57%
1 month-17.56%
3 months-15.18%
6 months-36.08%
Current year-22.62%
1 week 0.82
Extreme 0.8233
0.93
1 month 0.8
Extreme 0.8041
1.1
Current year 0.8
Extreme 0.8041
1.65
1 year 0.8
Extreme 0.8041
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.39
Manager TitleAgeSince
Chief Executive Officer 54 30/09/2024
Director of Finance/CFO 68 17/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 23/06/2020
Director/Board Member 54 31/08/2018
Director/Board Member 66 16/03/2022
Date Insider Type Main position Quantity % Market Cap.
10/07/26 Free

Chief Financial Officer

200,000 1.1490%
10/07/26 Free

Chief Executive Officer

400,000 2.2980%
13/06/26 Tax

Chief Executive Officer

-3,990 0.0229%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%+4.50%-32.15%-41.19% 15.49M
-0.22%+4.21%+26.13%+11.44% 224B
-0.06%+3.61%+0.56%-19.56% 146B
-0.04%+6.71%-16.28%+31.23% 142B
+0.91%+8.24%-49.65%+0.67% 74.19B
-0.43%+4.77%+21.16%+15.75% 53.99B
-1.41%-0.54%-15.65%-17.15% 50.85B
-0.71%+4.99%+26.28%+16.98% 42.22B
-0.33%+3.47%+44.95%+43.52% 40.75B
-0.11%+3.37%-2.42%+1.13% 32.86B
Average -0.51%+5.62%+0.29%+4.28% 80.61B
Weighted average by Cap. -0.18%+6.23%+3.90%+8.30%

Financials

2026 *2027 *
Net sales 53M 45.92M 43.02M 39.24M 73.78M 5.06B 74.91M 506M 198M 2.53B 199M 195M 8.44B 56.77M 49.18M 46.08M 42.03M 79.02M 5.41B 80.23M 542M 212M 2.71B 213M 209M 9.04B
Net income -795K -689K -645K -589K -1.11M -75.83M -1.12M -7.59M -2.97M -37.97M -2.98M -2.92M -127M 361K 313K 293K 267K 503K 34.43M 510K 3.45M 1.35M 17.24M 1.36M 1.33M 57.49M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
12/08/26 US$0.8821 -0.87% 88,050
11/08/26 US$0.8898 +5.69% 74,086
10/08/26 US$0.8419 +1.37% 66,681
07/08/26 US$0.8305 -1.08% 25,300
06/08/26 US$0.8396 -0.53% 12,827
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8898USD
Average target price
2.750USD
Spread / Average Target
+209.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock